DAIC

APRIL 6, 2024

However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack. The composite rate of total heart failure hospitalizations and death from heart failure was also 31% lower among those receiving empagliflozin.

Heart attacks 98

Heart attacks Heart Attack Heart Failure Outpatient 98

DAIC

FEBRUARY 27, 2024

“We are proud to have performed the first implant of this novel device, as it offers an alternative treatment for patients who remain significantly impacted by right heart dysfunction related to pulmonary hypertension, which has limited approved therapy options,” said Dr. Ashwin Ravichandran of Ascension St.

Pulmonary 110

Pulmonary Hypertension Heart Failure Blood Pressure 110

DAIC

APRIL 6, 2024

While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack, according to results from the EMPACT-MI trial presented on day one of the American College of Cardiology Scientific Sessions, ACC.24,

Heart attacks 81

Heart attacks Heart Attack Heart Failure Outcomes 81

Dr. Anish Koka

SEPTEMBER 24, 2022

So, of the 989 cases of myocarditis that were identified via VAERS, there is information on hospitalization status for 519 of them. We know that 484 (93%) of them were hospitalized. The final bit of bad news relates to the common laboratory and imaging tests cardiologists typically use to assess for heart dysfunction.

COVID-19 52

COVID-19 Hospital Chest Pain Quality of Life 52